ArticleNeurology2022

Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease.

Paula Barreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.